We are live on ! Find out more
ZYME icon

Zymeworks

43 hedge funds and large institutions have $132M invested in Zymeworks in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

13,800% more call options, than puts

Call options by funds: $278K | Put options by funds: $2K

2.31% more ownership

Funds ownership: 26.11%28.42% (+2.3%)

1% more capital invested

Capital invested by funds: $130M → $132M (+$1.61M)

7% less funds holding

Funds holding: 4643 (-3)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
8
Reduced
13
Closed
16
Calls
$278K
Puts
$2K
Net Calls
+$276K
Net Calls Change
+$276K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
51
BVF Inc
California
-$311K -19,804 Closed
Goldman Sachs
52
Goldman Sachs
New York
-$225K -14,302 Closed
LCM
53
Laurion Capital Management
New York
-$189K -12,032 Closed
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
-$49K -3,113 Closed
UBS Group
55
UBS Group
Switzerland
-$37K -2,386 Closed
TRCT
56
Tower Research Capital (TRC)
New York
-$5K -293 Closed
TL
57
TrueWealth LLC
Georgia
-$3K -217 Closed
KF
58
Krilogy Financial
Missouri
-$2K -100 Closed
Toronto Dominion Bank
59
Toronto Dominion Bank
Ontario, Canada
+$289 +22 New

ZYME Hedge Fund Activity: Q4 2018 in Review

43 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2018, worth a combined $132M — up 1.2% from $130M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ZYME and 13 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was Camber Capital Management, adding an estimated $10.4M. The largest seller was Perceptive Advisors, cutting an estimated $7.22M.

  • 43 institutional investors held Zymeworks (ZYME) as of Q4 2018, down from 46 in Q3 2018.
  • Funds reported $132M of Zymeworks stock for Q4 2018, up 1.2% quarter-over-quarter.
  • 13 funds opened new Zymeworks positions in Q4 2018 and 16 closed out, a net change of -3 holders.
  • The largest Zymeworks buyer in Q4 2018 was Camber Capital Management, an estimated $10.4M added.
  • The largest Zymeworks seller in Q4 2018 was Perceptive Advisors, an estimated $7.22M sold.

Based on aggregated 13F filings for Q4 2018.